| Filed On | Filing |
|---|---|
| 03 Jun 2026 |
Form 4: Pisano Wayne, Director
Granted 30,000 Stock Option |
| 03 Jun 2026 |
Form 4: Rigby Jonathan, Director
Granted 30,000 Stock Option |
| 03 Jun 2026 |
Form 4: Holtham Angela, Director
Granted 30,000 Stock Option |
| 03 Jun 2026 |
Form 4: Parsons James T., Director
Granted 30,000 Stock Option |
| 03 Jun 2026 |
Form 4: Look Kirk, Chief Financial Officer
Granted 260,000 Stock Option |
| 03 Jun 2026 |
Form 4: Aromando Andrew, Chief Business Officer
Granted 260,000 Stock Option |
| 03 Jun 2026 |
Form 4: Kelly Jared, Director
Granted 755,000 Stock Option |
| 03 Jun 2026 |
Form 4: Andrews Patricia S, Director
Granted 30,000 Stock Option |
| 03 Jun 2026 |
Form 4: Seizinger Bernd R., Director
Granted 30,000 Stock Option |
| 03 Jun 2026 |
Form 4: Hagerman Allison, Chief Technology Officer
Granted 260,000 Stock Option |
| 03 Jun 2026 |
Form 4: Brown Deborah Margaret, Director
Granted 30,000 Stock Option |
| 03 Jun 2026 |
Form 4: Heineman Thomas Charles, Chief Medical Officer
Granted 260,000 Stock Option |
| 03 Jun 2026 |
Form 4: McAdory John Bearden, Chief Operating Officer
Granted 145,000 Stock Option |
| 03 Jun 2026 |
Form 4: Glover Stephen C., Director
Granted 96,000 Stock Option |
| 13 Mar 2026 |
Form 4: Parsons James T., Director
Bought 10,000 shares ($10.3K) |
| 13 Mar 2026 |
Form 4: Kelly Jared, Director
Bought 5,050 shares ($4.85K) |
| 13 Feb 2026 |
Form 4: Look Kirk, Chief Financial Officer
Bought 12,000 shares ($10.1K) |
| 13 Feb 2026 |
Form 4: Pisano Wayne, Director
Bought 30,000 shares ($25.3K) |
| 13 Feb 2026 |
Form 4: Kelly Jared, Director
Bought 5,600 shares ($4.68K) · Bought 29,500 shares ($24.8K) |
| 13 Feb 2026 |
Form 4: Heineman Thomas Charles, Chief Medical Officer
Bought 12,132 shares ($10K) |
Loading...